Warner Pharmaceuticals (688799.SH): Loxoprofen sodium patch obtains drug registration certificate

Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for loxoprofen sodium patches approved and issued by the State Drug Administration. Loxoprofen sodium patches are used to reduce inflammation and pain in the following diseases and symptoms: osteoarthritis, muscle pain, and swelling or pain caused by trauma. The company's loxoprofen sodium patch obtained a drug registration certificate according to the new registration classification of 4 types of chemicals, which is considered to have passed the consistency evaluation.